Tumor necrosis factor‐α regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia
暂无分享,去创建一个
T. Billiar | A. Demetris | B. Harbrecht | R. Simmons | M. Silvio | A. Demetris | R. L. Simmons | M. D. Silvio
[1] O. Griffith,et al. Mammalian nitric oxide synthases. , 1999, Advances in enzymology and related areas of molecular biology.
[2] T. Billiar,et al. Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. , 1994, The American journal of physiology.
[3] L. Stellin,et al. Multiple system organ failure. , 1993, Annals of surgery.
[4] A. Nussler,et al. Inflammation, immunoregulation, and inducible nitric oxide synthase , 1993, Journal of leukocyte biology.
[5] T. Billiar,et al. Hepatocyte Injury by Activated Neutrophils In Vitro Is Mediated by Proteases , 1993, Annals of surgery.
[6] T. Billiar,et al. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin‐6 by rat Kupffer cells , 1993, Journal of leukocyte biology.
[7] T. Billiar,et al. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical‐mediated hepatic injury , 1992, Journal of leukocyte biology.
[8] C. Natanson,et al. N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin , 1992, The Journal of experimental medicine.
[9] H. Langstein,et al. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. , 1992, Journal of immunology.
[10] S. Moncada,et al. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? , 1991, The Lancet.
[11] P. Vallance,et al. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock , 1991, The Lancet.
[12] R. L. Simmons,et al. Modulation of Nitrogen Oxide Synthesis In Vivo: NG‐Monomethyl‐L‐Arginine Inhibits Endotoxin‐Induced Nitrate/Nitrate Biosynthesis While Promoting Hepatic Damage , 1990, Journal of leukocyte biology.
[13] R. Busse,et al. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells , 1990, FEBS letters.
[14] J. Adams,et al. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. , 1990, Biochemical and biophysical research communications.
[15] T. Billiar,et al. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. , 1990, Annals of surgery.
[16] T. Billiar,et al. Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes. , 1990, Biochemical and biophysical research communications.
[17] P. Belloni,et al. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. , 1990, Journal of the National Cancer Institute.
[18] M. Meltzer,et al. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. , 1990, Journal of immunology.
[19] H. Ford,et al. Characterization of wound cytokines in the sponge matrix model. , 1989, Archives of surgery.
[20] T. Billiar,et al. Inhibition of chemotaxis Ng-monomethyl-L-arginine: a role for cyclic GMP. , 1989, Blood.
[21] T. Billiar,et al. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells , 1989, The Journal of experimental medicine.
[22] K. Tracey,et al. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia , 1989, The Journal of experimental medicine.
[23] D. Stuehr,et al. An L-arginine-dependent mechanism mediates kupffer cell inhibition of hepatocyte protein synthesis in vitro , 1989, The Journal of experimental medicine.
[24] L. Ignarro. Endothelium‐derived nitric oxide: actions and properties , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] Kevin J. Tracey,et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.
[26] J. Hibbs,et al. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. , 1987, Journal of immunology.
[27] D. Fry,et al. Effective organ blood flow and bioenergy status in murine peritonitis. , 1986, Surgery.
[28] D. Stern,et al. Modulation of endothelial cell hemostatic properties by tumor necrosis factor , 1986, The Journal of experimental medicine.
[29] B. Beutler,et al. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. , 1985, Journal of immunology.
[30] M. Arthur,et al. Oxygen-derived free radicals promote hepatic injury in the rat. , 1985, Gastroenterology.
[31] B. Beutler,et al. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.
[32] S. Tannenbaum,et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.
[33] R. L. Fulton,et al. Multiple system organ failure. The role of uncontrolled infection. , 1980, Archives of surgery.
[34] M. Chiasson,et al. Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. , 1977, Journal of the National Cancer Institute.
[35] Ozawa Kazue,et al. A direct method for the estimation of ornithine carbamoyltransferase activity in serum. , 1976 .
[36] C. Dinarello. Interleukin-1 and its biologically related cytokines. , 1989, Advances in immunology.
[37] H. Schlayer,et al. Enhancement of neutrophil adherence to isolated rat liver sinusoidal endothelial cells by supernatants of lipopolysaccharide-activated monocytes. Role of tumor necrosis factor. , 1987, Journal of hepatology.
[38] J. Adams,et al. hypotension: Implications for the involvement of nitric oxide , 2022 .